Prof Jan Rosier – Elan Professor of the Business of Biotechnology, UCD Michael Smurfit Graduate Business School – with Dean of UCD School of Business, Prof Ciarán Ó hÓgartaigh.
Prof Jan Rosier – Elan Professor of the Business of Biotechnology, UCD Michael Smurfit Graduate Business School – with Elan representatives Emer Reynold, Head of Communications and Nigel Clerkin, CFO, Elan Corporation.
Prof Jan Rosier – Elan Professor of the Business of Biotechnology, UCD Michael Smurfit Graduate Business School – at the UCD Focus Event.
|Date||Wednesday, December 4th, 2013|
|Venue||UCD Michael Smurfit Graduate Business School, Carysfort Avenue, Blackrock, Co. Dublin|
|Time||6.00pm to 8.00pm|
Lecture abstract: Although the role of the CEO in innovation is a recurrent topic in business literature, how that role is discharged has received less attention. This is surprising as innovation has been empirically linked to competitiveness especially in life science R&D environments. When reflecting on their role in innovation, CEOs argue that they lack the skills and expertise as they ‘do not know how to do it’ or find the task ‘too complicated’. At the same time, R&D scientists are described as knowledge workers who fall outside full control of management but hold knowledge that can generate competitive advantage. If R&D represents powerful knowledge but resists managerial leadership, while CEOs wish to impact firm innovation but have difficulties doing so, how can they play a role in innovation?
|6:00-6:30pm||Registration & tea/coffee on arrival|
|7:30pm||Closing remarks. Guests are invited to attend post-lecture reception.|
Meet the speaker
Professor Jan Rosier
Professor Jan Rosier is Élan Professor of the Business of Biotechnology at UCD School of Business . His appointment is part of an initiative, between UCD and Élan Corporation plc, designed to create a leadership position in the global biotechnology industry and marks the establishment of Europe’s first interdisciplinary Chair in the “Business of Biotechnology.”
Prior to joining UCD, Prof. Rosier held the positions of CEO of Formac Pharmaceuticals NV in Leuven, Belgium, and Vice President for drug development at Johnson & Johnson in Beerse, Belgium. He has a Ph.D. in Pharmaceutical Sciences from Ghent University, and was a Fulbright Scholar at Harvard University.
Since 2008, he lectures in new drug development at the University of Leuven, Belgium. At the UK’s Cranfield School of Management, Prof. Rosier conducts research on the management of life science R&D, as a visiting fellow, and will complete his second Ph.D. in Management in 2013.
He was awarded a NATO research fellowship for his research conducted at MIT and twice received the Johnson & Johnson Leadership Award for ‘outstanding and exceptional contribution’ in the development of two AIDS drugs. He has also had numerous scientific papers published in leading high impact science journals.
Prof. Rosier’s appointment, generously funded by Élan, is a joint appointment between the UCD College of Science and UCD School of Business, and will see him lead teaching and research at the interface between business and biotechnology.
The UCD Élan initiative (launched in 2011) includes in addition to this newly established Chair, two postdoctoral scholarships as well as an annual lecture series highlighting management leadership in the dynamic world of biotechnology globally.